These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19017766)

  • 41. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes.
    Egede LE; Mueller M; Echols CL; Gebregziabher M
    Med Care; 2010 Jun; 48(6):527-33. PubMed ID: 20473215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study.
    Weinstock RS; Teresi JA; Goland R; Izquierdo R; Palmas W; Eimicke JP; Ebner S; Shea S;
    Diabetes Care; 2011 Feb; 34(2):274-9. PubMed ID: 21270184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).
    Agrawal L; Emanuele NV; Abraira C; Henderson WG; Levin SR; Sawin CT; Silbert CK; Nuttall FQ; Comstock JP; Colwell JA
    Diabetes Care; 1998 Apr; 21(4):510-5. PubMed ID: 9571333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial.
    Sharp LK; Tilton JJ; Touchette DR; Xia Y; Mihailescu D; Berbaum ML; Gerber BS
    Pharmacotherapy; 2018 Jan; 38(1):58-68. PubMed ID: 29121408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups.
    Hompesch M; Troupin B; Heise T; Elbroend B; Endahl L; Haahr H; Heinemann L
    Diabetes Obes Metab; 2006 Sep; 8(5):568-73. PubMed ID: 16918592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.
    Davidson JA; McMorn SO; Waterhouse BR; Cobitz AR
    Clin Ther; 2007 Sep; 29(9):1900-14. PubMed ID: 18035190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control.
    Okosun IS; Dever GE
    Obes Res; 2002 Dec; 10(12):1241-50. PubMed ID: 12490668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemoglobin A(₁c) criterion for diabetes diagnosis among Hispanic and non-Hispanic populations.
    Getaneh A; Andres R; Brillon DJ; Findley SE
    Endocr Pract; 2011; 17(2):210-7. PubMed ID: 20841311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus.
    Davidson JA; Lacaya LB; Jiang H; Heilmann CR; Scism-Bacon JL; Gates JR; Jackson JA
    Endocr Pract; 2010; 16(5):818-28. PubMed ID: 20439249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing racial/ethnic disparities in diabetes: the Coached Care (R2D2C2) project.
    Kaplan SH; Billimek J; Sorkin DH; Ngo-Metzger Q; Greenfield S
    J Gen Intern Med; 2013 Oct; 28(10):1340-9. PubMed ID: 23645452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to diabetes self care for white, African-American and Hispanic American telemedicine participants: 5 year results from the IDEATel project.
    Trief PM; Izquierdo R; Eimicke JP; Teresi JA; Goland R; Palmas W; Shea S; Weinstock RS
    Ethn Health; 2013; 18(1):83-96. PubMed ID: 22762449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of diabetes control on mortality by race in a national cohort of veterans.
    Hunt KJ; Gebregziabher M; Lynch CP; Echols C; Mauldin PD; Egede LE
    Ann Epidemiol; 2013 Feb; 23(2):74-9. PubMed ID: 23238350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disparities in alcohol-related problems among white, black, and Hispanic Americans.
    Mulia N; Ye Y; Greenfield TK; Zemore SE
    Alcohol Clin Exp Res; 2009 Apr; 33(4):654-62. PubMed ID: 19183131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemoglobin A1c Testing and Amputation Rates in Black, Hispanic, and White Medicare Patients.
    Suckow BD; Newhall KA; Bekelis K; Faerber AE; Gottlieb DJ; Skinner JS; Stone DH; Goodney PP
    Ann Vasc Surg; 2016 Oct; 36():208-217. PubMed ID: 27474195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk for metabolic control problems in minority youth with diabetes.
    Delamater AM; Shaw KH; Applegate EB; Pratt IA; Eidson M; Lancelotta GX; Gonzalez-Mendoza L; Richton S
    Diabetes Care; 1999 May; 22(5):700-5. PubMed ID: 10332669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments.
    Aikens JE; Piette JD
    Diabetes Care; 2009 Jan; 32(1):19-24. PubMed ID: 18852334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes.
    Egede LE; Gebregziabher M; Hunt KJ; Axon RN; Echols C; Gilbert GE; Mauldin PD
    Ann Pharmacother; 2011 Feb; 45(2):169-78. PubMed ID: 21304026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of gastroesophageal reflux symptoms in adolescents: is there a difference in different racial and ethnic groups?
    Gunasekaran TS; Dahlberg M
    Dis Esophagus; 2011 Jan; 24(1):18-24. PubMed ID: 20626447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Race as a factor for intensification of diabetes medications.
    Bullock KC; Edwards KL; Greene RS; Shah SR; Blaszczyk AT
    Diabetes Educ; 2013; 39(3):335-43. PubMed ID: 23475185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.